Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Art therapy tested as a new way to ease PTSD in soldiers

NCT ID NCT05414708

Symptom relief Sponsor: Walter Reed National Military Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether art therapy can help active-duty military and recent veterans who have PTSD symptoms. Forty participants will attend 11 sessions over 6-8 months, including art therapy with a certified therapist and two MRI brain scans. The goal is to see if art therapy improves emotional expression and regulation, and how it affects brain activity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Art therapy
What this could lead to
If it works, this could point toward a non-drug treatment for PTSD that helps people better understand and manage their emotions.
What could go wrong
This is a very small, early study with only 40 people, so results may not apply to everyone. It also relies on self-reported feelings and brain scans, which may not show clear benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2022

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 64 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * DEERS Eligible * Active Duty or Veteran separated within the past 10 years * Significant posttraumatic stress symptoms (score of \>/=31 on the PCL-5) Exclusion Criteria: * History of moderate, severe, or penetrating brain injury * History of psychotic disorder, bipolar disorder, or active suicidal or homicidal ideation * History of multiple sclerosis, Huntington's disease, or Alzheimer's disease * History of stroke or myocardial infarction * History of brain tumor * History of seizures * Contradictions for MRI (for example, participants will be excluded for pregnancy, metal implants or suspected shrapnel, aneurysm/intracranial clips, cardiac pacemakers or implanted programmable devices or pumps) * Unable to provide informed consent * History of previous exposure to art therapy * Active substance use disorder

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANGER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

combat disorder Emotional Regulation Parasomnias Post-Traumatic Headache post-traumatic stress disorder sleep disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANGER Combat and operational stress reaction Combat stress disorders Emotion processing Emotional regulation Irritable mood Military activity Military family Military operations Nightmare Post-traumatic headache Posttraumatic stress disorder Posttraumatic stress disorder, delayed onset PTSD Sleep disturbance

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • ISC at Fort Belvoir

    RECRUITING

    Fort Belvoir, Virginia, 22060, United States

  • National Intrepid Center of Excellence

    RECRUITING

    Bethesda, Maryland, 20814, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.